BUS 393 Lecture Notes - Lecture 4: Purdue Pharma, Canadian Medical Association Journal, Bayer
Document Summary
Topic one: introduction to the canadian legal system, law and business strategy. Case one: the law, business strategy, patents and social impact: how a little-known patent sparked canada"s opioid crisis: the untold story of how a single pill sparked. Canada"s opioid crisis, and ignited one of the biggest pharmaceutical battles in. Canadian history (the globe and mail, by darryl dyck, grant robertson and. In the fall of 1992, a relatively unknown pharmaceutical company based in pickering, Ont. , filed a 47-page document with the canadian intellectual property office, seeking to patent a new invention it said could transform the way doctors treat pain. Like the millions of patent applications before it, the one filed in gatineau, que. , by the. Canadian subsidiary of u. s. drug giant purdue pharma promised remarkable things. The company"s researchers had surprisingly discovered a new way to treat pain.